BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21436712)

  • 1. Previous antiretroviral therapy for prevention of mother-to-child transmission of HIV does not hamper the initial response to PI-based multitherapy during subsequent pregnancy.
    Briand N; Mandelbrot L; Blanche S; Tubiana R; Faye A; Dollfus C; Le Chenadec J; Benhammou V; Rouzioux C; Warszawski J;
    J Acquir Immune Defic Syndr; 2011 Jun; 57(2):126-35. PubMed ID: 21436712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of short-course antenatal antiretroviral therapy on viral load and mother-to-child transmission in subsequent pregnancies among HIV-infected women.
    French CE; Tookey PA; Cortina-Borja M; de Ruiter A; Townsend CL; Thorne C
    Antivir Ther; 2013; 18(2):183-92. PubMed ID: 23475123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of antiretroviral therapy on pregnancy outcome in HIV-1 positive women.
    Kowalska A; Niemiec T; El Midaoui A; Burkacka E
    Med Wieku Rozwoj; 2003; 7(4 Pt 1):459-68. PubMed ID: 15010556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception.
    Mandelbrot L; Tubiana R; Le Chenadec J; Dollfus C; Faye A; Pannier E; Matheron S; Khuong MA; Garrait V; Reliquet V; Devidas A; Berrebi A; Allisy C; Elleau C; Arvieux C; Rouzioux C; Warszawski J; Blanche S;
    Clin Infect Dis; 2015 Dec; 61(11):1715-25. PubMed ID: 26197844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of genotypic resistance to nelfinavir among women exposed to prophylactic antiretroviral therapy during pregnancy.
    Kakehasi FM; Tupinambás U; Cleto S; Aleixo A; Lin E; Melo VH; Aguiar RA; Pinto JA
    AIDS Res Hum Retroviruses; 2007 Dec; 23(12):1515-20. PubMed ID: 18160009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Factors associated with virological response in women receiving highly-active antiretroviral prophylaxis for HIV-1 mother-to-child transmission].
    Palacios R; Senise JF; Vaz MJ; Castelo A
    Enferm Infecc Microbiol Clin; 2008; 26(7):411-5. PubMed ID: 18842235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current treatment strategies, complications and considerations for the use of HIV antiretroviral therapy during pregnancy.
    Senise JF; Castelo A; Martínez M
    AIDS Rev; 2011; 13(4):198-213. PubMed ID: 21975356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
    Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
    PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy outcomes among ART-naive and ART-experienced HIV-positive women: data from the ICONA foundation study group, years 1997-2013.
    d'Arminio Monforte A; Galli L; Lo Caputo S; Lichtner M; Pinnetti C; Bobbio N; Francisci D; Costantini A; Cingolani A; Castelli F; Girardi E; Castagna A;
    J Acquir Immune Defic Syndr; 2014 Nov; 67(3):258-67. PubMed ID: 25314248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing prevention of HIV mother to child transmission: Duration of antiretroviral therapy and viral suppression at delivery among pregnant Malawian women.
    Chagomerana MB; Miller WC; Tang JH; Hoffman IF; Mthiko BC; Phulusa J; John M; Jumbe A; Hosseinipour MC
    PLoS One; 2018; 13(4):e0195033. PubMed ID: 29614083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug resistance among HIV-infected pregnant women receiving antiretrovirals for prophylaxis.
    Duran AS; Losso MH; Salomón H; Harris DR; Pampuro S; Soto-Ramirez LE; Duarte G; de Souza RS; Read JS;
    AIDS; 2007 Jan; 21(2):199-205. PubMed ID: 17197811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
    Ekouevi DK; Coffie PA; Becquet R; Tonwe-Gold B; Horo A; Thiebaut R; Leroy V; Blanche S; Dabis F; Abrams EJ
    AIDS; 2008 Sep; 22(14):1815-20. PubMed ID: 18753864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
    Panel de expertos de GESIDA y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4, viral load response, and adherence among antiretroviral-naive breast-feeding women receiving triple antiretroviral prophylaxis for prevention of mother-to-child transmission of HIV in Kisumu, Kenya.
    Okonji JA; Zeh C; Weidle PJ; Williamson J; Akoth B; Masaba RO; Fowler MG; Thomas TK
    J Acquir Immune Defic Syndr; 2012 Oct; 61(2):249-57. PubMed ID: 22692094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased risk of preterm delivery among HIV-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during pregnancy.
    Powis KM; Kitch D; Ogwu A; Hughes MD; Lockman S; Leidner J; van Widenfelt E; Moffat C; Moyo S; Makhema J; Essex M; Shapiro RL
    J Infect Dis; 2011 Aug; 204(4):506-14. PubMed ID: 21791651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological response to highly active antiretroviral therapy following treatment for prevention of mother to child transmission of HIV-1: a study in Côte d'Ivoire.
    Ekouevi DK; Coffie PA; Chaix ML; Tonwe-Gold B; Amani-Bosse C; Leroy V; Abrams EJ; Dabis F
    J Int AIDS Soc; 2010 Aug; 13():28. PubMed ID: 20678207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission.
    Cooper ER; Charurat M; Mofenson L; Hanson IC; Pitt J; Diaz C; Hayani K; Handelsman E; Smeriglio V; Hoff R; Blattner W;
    J Acquir Immune Defic Syndr; 2002 Apr; 29(5):484-94. PubMed ID: 11981365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with HIV RNA levels in pregnant women on non-suppressive highly active antiretroviral therapy at conception.
    European Collaborative Study
    Antivir Ther; 2010; 15(1):41-9. PubMed ID: 20167990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with viral load suppression in HIV-infected pregnant women in Rio de Janeiro, Brazil.
    Joao EC; Gouvêa MI; Menezes JA; Sidi LC; Cruz ML; Berardo PT; Ceci L; Cardoso CA; Teixeira Mde L; Calvet GA; Matos HJ
    Int J STD AIDS; 2012 Jan; 23(1):44-7. PubMed ID: 22362687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.